MCID: CNJ005
MIFTS: 15

Conjunctival Vascular Disease

Categories: Eye diseases, Cardiovascular diseases

Aliases & Classifications for Conjunctival Vascular Disease

MalaCards integrated aliases for Conjunctival Vascular Disease:

Name: Conjunctival Vascular Disease 12
Vascular Abnormalities of Conjunctiva 12
Vascular Abnormality of Conjunctiva 69
Conjunctival Vascular Abnormality 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10989
ICD10 33 H11.41
ICD9CM 35 372.74
NCIt 47 C35116
SNOMED-CT 64 193900004 74100001
UMLS 69 C0042370

Summaries for Conjunctival Vascular Disease

MalaCards based summary : Conjunctival Vascular Disease, is also known as vascular abnormalities of conjunctiva, and has symptoms including injected eye The drugs Travoprost and Bimatoprost have been mentioned in the context of this disorder. Affiliated tissues include eye and endothelial.

Related Diseases for Conjunctival Vascular Disease

Symptoms & Phenotypes for Conjunctival Vascular Disease

UMLS symptoms related to Conjunctival Vascular Disease:


injected eye

Drugs & Therapeutics for Conjunctival Vascular Disease

Drugs for Conjunctival Vascular Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 57)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Travoprost Approved Phase 4 157283-68-6 5282226
2
Bimatoprost Approved, Investigational Phase 4,Phase 3,Phase 2 155206-00-1 5311027
3
Latanoprost Approved, Investigational Phase 4,Phase 2 130209-82-4 5282380 5311221
4
Temazepam Approved Phase 4,Phase 3 846-50-4 5391
5
Timolol Approved Phase 4 26839-75-8 33624 5478
6
Maleic acid Experimental Phase 4 110-16-7 444266
7 Antihypertensive Agents Phase 4,Phase 3,Phase 2
8 Anti-Inflammatory Agents Phase 4
9 Ophthalmic Solutions Phase 4,Phase 2
10 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2
11 Anti-Anxiety Agents Phase 4,Phase 3
12 Central Nervous System Depressants Phase 4,Phase 3
13 GABA Agents Phase 4,Phase 3
14 GABA Modulators Phase 4,Phase 3
15 Hypnotics and Sedatives Phase 4,Phase 3
16 Neurotransmitter Agents Phase 4,Phase 3
17 Psychotropic Drugs Phase 4,Phase 3
18 Tranquilizing Agents Phase 4,Phase 3
19 Adrenergic Agents Phase 4
20 Adrenergic Antagonists Phase 4
21 Adrenergic beta-Antagonists Phase 4
22 Anti-Arrhythmia Agents Phase 4
23 Tetrahydrozoline Phase 4,Phase 2
24
Povidone Approved Phase 3 9003-39-8
25 Povidone-iodine Approved Phase 3 25655-41-8
26
Bevacizumab Approved, Investigational Phase 3 216974-75-3
27
Lidocaine Approved, Vet_approved Phase 3 137-58-6 3676
28
Iodine Investigational Phase 3 7553-56-2 807
29 cadexomer iodine Phase 3
30 Angiogenesis Inhibitors Phase 3
31 Angiogenesis Modulating Agents Phase 3
32
Ephedrine Approved Phase 2 299-42-3 9294
33
Pseudoephedrine Approved Phase 2 90-82-4 7028
34 Autonomic Agents Phase 2
35 Nasal Decongestants Phase 2
36 Peripheral Nervous System Agents Phase 2
37 Respiratory System Agents Phase 2
38 Vasoconstrictor Agents Phase 2
39
Ranibizumab Approved 347396-82-1 459903
40 Anti-Bacterial Agents
41 Antibiotics, Antitubercular
42 Anti-Infective Agents
43 Anti-Infective Agents, Local
44 Blood Substitutes
45 Micronutrients
46 Mitogens
47 Plasma Substitutes
48 Trace Elements
49 Antitubercular Agents
50 Alkylating Agents

Interventional clinical trials:

(show all 27)

id Name Status NCT ID Phase Drugs
1 Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes Completed NCT02136589 Phase 4 dicrofenac and travoprost
2 Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension Completed NCT01253902 Phase 4 bimatoprost ophthalmic solution 0.01%;travoprost ophthalmic solution 0.004%;latanoprost ophthalmic solution 0.005%
3 A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension Completed NCT02061683 Phase 4 Bimatoprost 0.03%
4 Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Completed NCT01298700 Phase 4 bimatoprost 0.01% ophthalmic solution;bimatoprost 0.03% ophthalmic solution
5 Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients. Completed NCT01997489 Phase 4 Enzyme replacement
6 20- Versus 23- Gauge System for Pars Plana Vitrectomy Completed NCT00411970 Phase 4
7 Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension Completed NCT00804648 Phase 4 Timolol Maleate in Sorbate;Timolol hemihydrate;Timolol maleate gel forming solution
8 Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose Recruiting NCT02017327 Phase 4 Monoprost;Lumigan 0.01%;Lumigan 0.03% Unit Dose
9 Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension Terminated NCT02047630 Phase 4 Generic latanoprost;Brand-name latanoprost
10 A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension Completed NCT01830140 Phase 3 Bimatoprost 0.01%;Bimatoprost 0.03%
11 Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy Active, not recruiting NCT01976923 Phase 3 Intravitreal bevacizumab
12 A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension Completed NCT00538304 Phase 2 bimatoprost eye drops;placebo
13 Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma Completed NCT01739244 Phase 2 SYL040012;Placebo
14 A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension Completed NCT01379144 Phase 2 latanoprost 75 ug;latanoprost 100 ug;latanoprost 125 ug;latanoprost 50 ug
15 A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma Completed NCT01936389 Phase 2 AR-12286
16 Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients Unknown status NCT02337972 povidone-iodine 4%
17 A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye Unknown status NCT01531842
18 Etiology and Prevalence of Peripheral Arterial Disease Completed NCT00005142
19 Resistance to Antibiotics in Patients Receiving Eye Injections Completed NCT02126423
20 Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of Ranibizumab Completed NCT00892398 ranibizumab
21 Assessment of Low-temperature Plasma Surgery System in Pterygium With Fibrin Glue and Conjunctival Autografts Completed NCT03204084
22 Clinical Applications of Advanced Ophthalmic Imaging Recruiting NCT03135327
23 Aqueous Dynamics and Glaucoma Surgeries Recruiting NCT02839590
24 Screening for Research Participants Recruiting NCT00655096
25 Uveitis/Intraocular Inflammatory Disease Biobank (iBank) Recruiting NCT02656381
26 Single Blind Randomized Study to Determine the Sensitivity and Specificity of 2 Non-invasive Markers of Early Coronary Disease Terminated NCT01742156
27 Tissue Studies of Human Eye Diseases Terminated NCT00001310

Search NIH Clinical Center for Conjunctival Vascular Disease

Genetic Tests for Conjunctival Vascular Disease

Anatomical Context for Conjunctival Vascular Disease

MalaCards organs/tissues related to Conjunctival Vascular Disease:

39
Eye, Endothelial

Publications for Conjunctival Vascular Disease

Variations for Conjunctival Vascular Disease

Expression for Conjunctival Vascular Disease

Search GEO for disease gene expression data for Conjunctival Vascular Disease.

Pathways for Conjunctival Vascular Disease

GO Terms for Conjunctival Vascular Disease

Sources for Conjunctival Vascular Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....